Company intelligence / Profile preview

Kineticx

Ownership: Private
Development stage: Commercial

Overview

QC Kinetix operates a large network of regenerative medicine clinics across the United States. They offer non-surgical treatments such as platelet-rich plasma and stem cell therapies to address joint pain and orthopedic conditions. The company claims to improve patient outcomes using minimally invasive procedures that leverage the body’s own healing mechanisms. No clinical trial data or peer-reviewed results are publicly available.

Therapeutic areas: OtherRheumatology
Modalities: Platelet-rich plasma therapyStem cell therapyPlasma-based therapyRegenerative medicine (general)
Industry: Non-Academic Healthcare

Partnerships

No major pharmaceutical or biotech partnerships disclosed; business model is direct-to-patient via franchised/regional clinics.

Beyond the preview

Go deeper on Kineticx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kineticx.

Explore the full profile